🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fred Schultz

ORCID: 0000-0002-6918-2290

MedicineImmunology and MicrobiologyMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity”.

Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0300

N/A

0DataRank · unranked

27 citations

Irina V. Lagutina, Kathryn J. Brayer, Fred Schultz, Danielle Burke, V. Shane Pankratz +5 more

The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis

Antiviral Research(2023)10.1016/j.antiviral.2023.105667

N/A

0DataRank · unranked

3 citations

Jesse M. Young, Rosa T. Sterk, Virginie Bondu, Fred Schultz, Donna F. Kusewitt +3 more

Inhibition of Cellular MEK/ERK Signaling Suppresses Murine Papillomavirus Type 1 Replicative Activities and Promotes Tumor Regression

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.14.532042

N/A

0DataRank · unranked

1 citations

Jesse M. Young, Rosa T. Sterk, Virginie Bondu, Fred Schultz, Donna F. Kusewitt +3 more